Penn Medicine Provider
Cardiology
Janice Pieretti, MD, FACC
4.9
(485)
Accepting new patients
Sees patients age 18 and up
Penn Heart and Vascular Center Radnor
View 1 additional location

About me

  • Associate Professor of Clinical Medicine (Cardiovascular Medicine)

Education and training

  • Medical School: Mount Sinai School of Medicine
  • Residency: NewYork-Presbyterian/Weill Cornell Medical Center
  • Fellowship: Temple University Hospital
  • Fellowship: Newark Beth Israel Medical Center

What my patients think about me

Average Rating
4.9

486 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
she was very thorough.
May 2025
5.0
5.0
just the best
May 2025
5.0
5.0
great care
April 2025
5.0
5.0
she is caring intelligent i feel secure after seeing her wonderful doc

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Pieretti is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Obici L, Ajroud-Driss S, Lin KP, Berk JL, Gillmore JD, Kale P, Koike H, Danese D, Aldinc E, Chen C, Vest J, Adams D; HELIOS-A Collaborators Study Group. Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy. , Neurology and Therapy , 12(5): 2023,1759-1175


Wilcox NS, Prenner SB, Cevasco M, Condit C, Goldstein A, Peterson JT, Tondi Resta I, Palmer M, Lal P, Owens AT, Pieretti J, Drivas TG, Reza N. End Stage Mitochondrial Cardiomyopathy and Heart Transplantation Due to Biallelic Pathogenic C1QBP Variants , Circ Genom Precis Med: 2022


Liang JJ, Frankel DS, Pieretti J, Deshpande C, Nazarian S Diagnosis of cardiac amyloidosis in patients undergoing catheter ablation for atrial arrhythmias , Journal of Interventional Cardiac Electrophysiology , 57: 2020,489-490


Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy , New England Journal of Medicine, 379(11): 2018,1007-1016


D.A. Baran, K. Liaquat, J. Pieretti, C. Gidea, M. Munagala, M. Camacho, C. Patel, M. Divita, M.J. Zucker Too Much Information: Interaction of Donor Sequence and Acceptance in the UNOS Database. , Journal of Heart and Lung Transplantation, 35(4s): 2016,S86


Baran DA, Rao P, Deo D, Liaquat K, Pieretti J, Gidea C, Munagala M, Zucker MJ Lack of Rejection Despite Period of No Immunosuppression: The NoTac Case Series. , Journal of Heart and Lung Transplantation, 35(4): 2016,S282


Tayal R, Pieretti J, Baran DA Severe systemic vasospasm causing recurrent cardiac arrest after orthotopic heart transplantation. , J Heart Lung Transplant, 32(12): 2013,1271–2


Baran DA, Gidea CG, Pieretti J, Guererro-Miranda CY, Weiss JA, Camacho M, Zucker MJ, Correlates of long­ term survival in the TICTAC Trial. , Journal of Heart and Lung Transplantation , 32(4): 2013,S135–S136


Baran DA, Vefali H, Costa V, Guerrero-Miranda JA, Weiss J, Pieretti J, Gidea CG, Camacho M, Zucker MJ Incidence of malignancy on tacrolimus monotherapy versus combination therapy: a report from the TICTAC Trial. , Journal of Heart and Lung Transplantation, 32(4): 2013,S40


Baran, DA, Pieretti, J, Gidea CG, Weiss JA, Guerrero-Miranda CY, Vefali H, Costa V, Camacho M, Zucker MJ Incidence of allograft vasculopathy in the TICTAC Trial as compared to a real world cohort. , Journal of Heart and Lung Transplantation, 32(4S): 2013,S26